TrialThe British journal of ophthalmology2003

A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

D G Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.